Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl- 2-dependent and independent mechanisms

American Journal of Pathology

Volumn 151, Issue 6, 1997, Pages 1775-1784

  Karsan, Aly ^a,e   Yee, Esther ^b   Poirier, Guy G ^c   Zhou, Ping ^d   Craig, Ruth ^d   Harlan, John M ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITÉ LAVAL   (Canada)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

^e ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RETROVIRUS; SIGNAL TRANSDUCTION; VASCULAR RESISTANCE;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL DEATH; CELLS, CULTURED; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; HUMANS; LYMPHOKINES; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TETRADECANOYLPHORBOL ACETATE; TYROSINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030696785     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Gibbons GH, Dzau VJ: The emerging concept of vascular remodeling. N Engl J Med 1994, 330:1431-1437
2. Han DKM, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G: Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol 1995, 147:267-277
3. Isner JM, Kearney M, Bortman S, Passeri J: Apoptosis in human atherosclerosis and restenosis. Circulation 1995, 91:2703-2711
4. Geng WJ, Libby P: Evidence for apoptosis in advanced human atheroma: co-localization with interleukin-1β-converting enzyme. Am J Pathol 1995, 147:251-266
5. Cho A, Courtman DW, Langille BL: Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ Res 1995, 76:168-175
6. Hobson B, Denekamp J: Endothelial proliferation in tumours and normal tissues: continuous labelling studies. Br J Cancer 1984, 49: 405-413
7. Reed J: Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994, 124:1-6
8. Ruoslahti E, Reed JC: Anchorage dependence, integrins, and apoptosis. Cell 1994, 77:477-478
9. Vaux DL, Cory S, Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988, 335:440-442
10. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990, 348:334-336
11. Yin X-M, Oltvai ZN, Korsmeyer SJ: BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization of with Bax. Nature 1994, 369:321-323
12. Borner C, Martinou I, Matmann C, Irmler M, Schaerer E, Martinou J-C, Tschopp J: The protein Bcl-2α does not require membrane attachment, but two conserved domains to suppress apoptosis. J Cell Biol 1994, 126:1059-1068
13. Sato T, Hanada M, Bodrug S, Irie S, Iwama N, Boise LH, Thompson CB, Golemis E, Fong L, Wang H-G, Reed JC: Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA 1994, 91:9238-9242
14. Reynolds JE, Yang T, Qian L, Jenkinson JD, Zhou P, Eastman A, Craig RW: Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-myc over-expression in Chinese hamster ovary cells. Cancer Res 1994, 54:6348-6352
15. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: bd-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993, 74:597-608
16. Lin EY, Orlofsky A, Wang H-G, Reed JC, Prystowsky MB: A1, a Bcl-2 family member, prolongs cell survival and permits myeloid differentiation. Blood 1996, 87:983-992
17. Karsan A, Yee E, Kaushansky K, Harlan JM: Cloning of a human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. Blood 1996, 87:3089-3096
18. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993, 74:609-619
19. Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson CB, Korsmeyer SJ: Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc Natl Acad Sci USA 1995, 92:7834-7838
20. Knudson CM, Tung KSK, Tourtellote WG, Brown GAJ, Korsmeyer SJ: Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 1995, 270:96-98
21. Araki S, Shimada Y, Kaji K, Hayashi H: Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem Biophys Res Commun 1990, 168:1194-1200
22. Harlow E, Lane D: Antibodies: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1988
23. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW: MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci USA 1993, 90:3516-3520
24. Yang T, Kozopas KM, Craig RW: The intracellular distribution and pattern expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2. J Cell Biol 1995, 128:1173-1184
25. Lamarre D, Talbot B, de Murcia G, Laplante C, Leduc Y, Mazen A, Poirier GG: Structural and functional analysis of poly (ADP-ribose) polymerase: an immunological study. Biochim Biophys Acta 1988, 950:147-160
26. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973, 52:2745-2756
27. Maciag T, Cerundolo J, Ilsley S, Kelley PR, Forand R: An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. Proc Natl Acad Sci USA 1979, 76:5674-5678
28. Miller AD, Rosman GJ: Improved retroviral vectors for gene transfer and expression. BioTechniques 1989, 7:980-990
29. Duke RC, Cohen JJ: Morphological and biochemical assays of apoptosis. Current Protocols in Immunology, vol. 1. Edited by Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W. New York, Wiley, 1994, p 3.17.11
30. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ: bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 1991, 67:879-888
31. Desnoyers S, Shah GM, Brochu G, Poirier GG: Erasable blot of poly (ADP-ribose) polymerase. Anal Biochem 1994, 218:470-473
32. Bombeli T, Karsan A, Tait JF, Harlan JM: Apoptotic vascular endothelial cells become procoagulant. Blood 1997, 89:2429-2442
33. Miller AD, Miller DG, Garcia JV, Lynch CM: Use of retroviral vectors for gene transfer and expression. Methods Enzymol 1993, 217:581-599
34. Kondo S, Yin D, Aoki T, Takanashi JA, Morimura T, Takeuchi J: bcl-2 gene prevents apoptosis of basic fibroblast growth factor-deprived murine aortic endothelial cells. Exp Cell Res 1994, 214:428-432
35. Hoyt DG, Rusnak JM, Mannix RJ, Modzelewski RA, Johnson CS, Lazo JS: Integrin activation suppresses etoposide-induced DNA strand breakage in cultured murine tumor-derived endothelial cells. Cancer Res 1996, 56:4146-4149
36. Hoyt DG, Mannix RJ, Rusnak JM, Pitt BR, Lazo JS: Collagen is a survival factor against LPS-induced apoptosis in cultured sheep pulmonary artery endothelial cells. Am J Physiol 1995, 269:L171-177
37. Meredith JE, Fazeli BJ, Schwartz MA: The extracellular matrix as a cell survival factor. Mol Biol Cell 1993, 4:953-961
38. Enenstein J, Waleh NS, Kramer RH: Basic FGF and TGF-β differentially modulate integrin expression of human microvascular endothelial cells. Exp Cell Res 1992, 203:499-503
39. Klein S, Giancotti FG, Presta M, Albelda SM, Buck CA, Rifkin DB: Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells. Mol Biol Cell 1993, 4:973-982
40. Kauffman SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG: Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 1993, 53:3976-3985
41. Martin SJ, O'Brien GA, Nishioka WK, McGahon AJ, Mahboubi A, Saido TC, Green DR: Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J Biol Chem 1995, 270:6425-6428
42. Casciola-Rosen LA, Miller DK, Anhalt GJ, Rosen A: Specific cleavage of the 70-kd protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem 1994, 269:30757-30760
43. Gjertsen BT, Doskeland SO: Protein phosphorylation in apoptosis. Biochim Biophys Acta 1995, 1269:187-199
44. Pober JS, Cotran RS: Cytokines and endothelial cell biology. Physiol Rev 1990, 70:427-451
45. Pearson JD: Endothelial cell function and thrombosis. Baillieres Clin Haematol 1994, 7:441-452
46. Friesel RE, Maciag T: Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J 1995, 9:919-925
47. Fuks Z, Persaud RS, Alfieri A, McLoughlin M, Ehleiter D, Schwartz JL, Seddon AP, Cordon-Cardo C, Haimovitz-Friedman A: Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death. Cancer Res 1994, 54:2582-2590
48. Kinoshita T, Yokota T, Arai K, Miyajima A: Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors. EMBO J 1995, 14:266-275
49. Karsan A, Yee E, Harlan JM: Endothelial cell death induced by tumor necrosis factor-α is inhibited by the Bcl-2 family member, A1. J Biol Chem 1996, 271:27201-27204
50. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ: Deregulated bCl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 1990, 144:3602-3610
51. Re F, Zanetti A, Sironi M, Polentarutti N, Lanfrancone L, Dejana E, Colotta F: Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol 1994, 127: 537-546
52. 3 during angiogenesis. J Clin Invest 1996, 98:426-433
53. Wary KK, Mainiero F, Isakoff SJ, Marcantonio EE, Giancotti FG: The adaptor protein She couples a class of integrins to the control of cell cycle progression. Cell 1996, 87:733-743
54. Varani J, Dame MK, Taylor CG, Sarma V, Merino R, Kunkel RG, Nunez G, Dixit VM: Age-dependent injury in human umbilical vein endothelial cells: relationship to apoptosis and correlation with a lack of A20 expression. Lab Invest 1995, 73:851-858
55. Garfinkel S, Hu X, Prudovsky IA, McMahon GA, Kapnik EM, McDowell SD, Maciag T: FGF-1-dependent proliferate and migratory responses are impaired in senescent human umbilical vein endothelial cells and correlate with the inability to signal tyrosine phosphorylation of fibroblast growth factor receptor-1 substrates. J Cell Biol 1996, 134:783-791
56. Wang E: Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved. Cancer Res 1995, 55:2284-2292
57. Gardner AM, Johnson GL: Fibroblast growth factor-2 suppression of tumor necrosis factor α-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase. J Biol Chem 1996, 271:14560-14566
58. Haldar S, Jena N, Croce CM: Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 1995, 92:4507-4511